In the case of elevated p53β:TAp53, the association with less aggressive melanoma may also be driven by lower TAp53 levels, which may indicate functionally active full-length p53 as opposed to overexpression of the tumour suppressor, which has been linked to cell survival and treatment resistance in melanoma [7]. This evidence concerns the gene TP53 and melanoma.